|
⚲
|
| Keyboard |
| Lifecore Biomedical Inc
✚
|
|
|---|---|
| CIK # | 0000028626 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0000028626] | |
| SC 13G | [0000028626] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| David Capital Partners LLC | Lifecore Biomedical Inc | [2024-11-12] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lifecore Biomedical Inc LFCR
Series A Convertible Preferred Stock · derivative
|
2023-01-09 | Buy | 1,560 | $1,000.00 | 1,560,000 |
|
Lifecore Biomedical Inc LFCR
Series A Convertible Preferred Stock · derivative
|
2023-01-09 | Buy | 650 | $1,000.00 | 650,000 |
|
Lifecore Biomedical Inc LFCR
Series A Convertible Preferred Stock · derivative
|
2023-01-09 | Buy | 1,040 | $1,000.00 | 1,040,000 |
|
Lifecore Biomedical Inc LFCR
Common Stock, $0.001 par value per share
|
2022-11-25 | Buy | 345,260 | $7.97 | 2,751,722 |
|
Lifecore Biomedical Inc LFCR
Common Stock, $0.001 par value per share
|
2022-11-25 | Buy | 282,486 | $7.97 | 2,251,413 |